Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EASE: Topical Herbal Plasters for Cancer Pain
NCT07447856Phase 1Recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Feb 2026
- Primary completion
- Feb 2028
- Modality
- Hydrogel Systems, Transdermal Patches
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Qizheng Xiaotong Plaster in cancer pain (2 arms), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoints: Enrollment rate at 2 years, Treatment adherence rate at 2 years and 2 more. Started Feb 2026; status: recruiting.
02
Drugs
Qizheng Xiaotong Plaster
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT07447856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07447856.